Overview

Taltz in Combination With Enstilar for Psoriasis

Status:
Recruiting
Trial end date:
2021-03-30
Target enrollment:
Participant gender:
Summary
Enstilar in combination with Taltz for plaque psoriasis.
Phase:
Phase 4
Details
Lead Sponsor:
Psoriasis Treatment Center of Central New Jersey
Collaborator:
Eli Lilly and Company
Treatments:
Calcipotriene